Financhill
Back

Harmony Biosciences Holdings Quote, Financials, Valuation and Earnings

Unlock the Secret to Earning Monthly Income!

Limited spots act swiftly
Buy
75

HRMY
Harmony Biosciences Holdings

Last Price:
31.58
Seasonality Move:
3.71%

7 Day Trial

ALL ACCESS PASS

$ 7

Will Crypto Make People Rich Again Starting April 2024?

Details on how to profit here.

Harmony Biosciences Holdings Price Quote

$31.58
+0.01 (+-0.32%)
(Updated: May 4, 2024 at 6:23 AM ET)

Harmony Biosciences Holdings Key Stats

Buy
75
Harmony Biosciences Holdings (HRMY) is a Buy

Day range:
$31.17 - $32.37
52-week range:
$18.61 - $39.27
Dividend yield:
0%
P/E ratio:
14.82
P/S ratio:
3.04
P/B ratio:
3.48%

Volume:
546K
Avg. volume:
440.1K
1-year change:
-12.28%
Market cap:
$1.8B
Revenue:
$582M
EPS:
$2.31

How Much Does Harmony Biosciences Holdings Make?

Is Harmony Biosciences Holdings Growing As A Company?

Harmony Biosciences Holdings Stock Price Performance

What Is Harmony Biosciences Holdings 52-Week High & Low?

Harmony Biosciences Holdings Price To Free Cash Flow

Is It Risky To Buy Harmony Biosciences Holdings?

Is Harmony Biosciences Holdings Cash Flow Positive?

  • What Is HRMY Cash Flow From Operations?
    Cash flow from operations (TTM) is $208M
  • What Is Harmony Biosciences Holdings’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$112.6M
  • What Is Harmony Biosciences Holdings’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$50.8M

Harmony Biosciences Holdings Return On Invested Capital

  • Is Management Doing A Good Job?
    HRMY return on invested capital is 20.52%
  • What Is Harmony Biosciences Holdings Return On Assets?
    ROA measures how assets are converting to revenues and is 17.6%
  • What Is HRMY Return On Equity?
    ROE is a measure of profitability and is 28.79%

Harmony Biosciences Holdings Earnings Date & Stock Price

Harmony Biosciences Holdings Competitors

Harmony Biosciences Holdings Dividend Yield

Data Unavailable

Harmony Biosciences Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 39.58% 26.92%
Revenue: 29.79% 0.18%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 42.25
Upside from Last Price: 33.83%

Major Shareholders

  • How many HRMY shares are owned by institutional investors?
    68.6M HRMY shares are owned by institutional investors
  • How many HRMY shares are owned by insiders?
    259.9K HRMY shares are owned by insiders